Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research

Author:

Kolomejtseva Alina A.ORCID,Bokova Svetlana E.ORCID

Abstract

Background. Breast cancer is the most common cancer in women. Metastatic breast cancer is an incurable disease, the main treatment goals of which are to increase overall survival and improve quality of life. Aim. To assess the priorities of patients with breast cancer in the framework of a sociological study. Materials and methods. For the first time, the main results of a sociological study of patients diagnosed with breast cancer, conducted by the Interregional Public Movement "Movement Against Cancer" in OctoberNovember 2021. This analysis reflects the needs of patients with breast cancer in various regions of the Russian Federation. A total of 675 people were interviewed,662 questionnaires were allowed for analysis. Results. In the rating of patients' desires regarding the results of treatment, regardless of the region and the duration of the course of the disease, the leading positions were taken by "improved quality of life" (46.2%) and "increased life expectancy" (46.4%). In the rating of preferences regarding the therapy received, the first place was taken by the value It is important to maintain good health, working capacity and the ability to live a full life (39.1%). Conclusion. The priority for all patients diagnosed with breast cancer is an effective and safe treatment that will ensure a good health and performance and safe a high quality of life for a long time.

Publisher

Consilium Medicum

Subject

Cancer Research,Oncology

Reference19 articles.

1. Состояние онкологической помощи населению России в 2019 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М. 2020 [Sostoianie onkologicheskoi pomoshchi naseleniiu Rossii v 2019 godu. Pod red. AD Kaprina, VV Starinskogo, AO Shakhzadovoi. Moscow. 2020 (in Russian)].

2. The Recurrence Rate, Risk Factors and Recurrence Patterns after Surgery in 3700 Patients with Operable Breast Cancer

3. 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

4. Yersal O, Barutсa S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J Clin Oncol. 2014;5(3):412-24.

5. Bonotto M, Gerratana L, Poletto E, et al. Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario. Oncologist. 2014;19(6):608-15.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3